XML 59 R23.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-based Compensation Arrangement by Share-based Payment Award Options and Warrants Vested and Expected to Vest Outstanding and Exercisable [Table Text Block] | The Black-Scholes assumptions used in the years ended December 31, 2014, 2013 and 2012 are as follows:
|  | Year ended December 31,
|  | 2014 |  | 2013 |  | 2012
Exercise price |  |  | $1.46 – $2.91 |  |  |  | $1.64 – $1.74 |  |  |  | $1.69 – $2.47 |
Expected dividends |  |  | 0% |  |  |  | 0% |  |  |  | 0% |
Expected volatility |  |  | 101% – 150% |  |  |  | 141% – 154% |  |  |  | 108% – 174% |
Risk free interest rate |  |  | 1.57% – 2.73% |  |  |  | 0.77% – 2.54% |  |  |  | 0.37% – 1.98% |
Expected life of option |  |  | 5 years – 10 years |  |  |  | 5 – 10 years |  |  |  | 5 – 10 years |
Expected forfeitures |  |  | 0% |  |  |  | 0% |  |  |  | 0% |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | A summary of stock option activities for the years ended December 31, 2014, 2013 and 2012, is as follows:
|  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value
Balance – December 31, 2011 |  |  | 2,979,010 |  |  | $ | 1.34 |  |  |  | 6.01 years |  |  | $ | — |
Granted |  |  | 2,075,000 |  |  | $ | 2.21 |  |  |  |  |  |  |  |  |
Exercised |  |  | (374,851 | ) |  | $ | 0.34 |  |  |  |  |  |  | $ | 661,000 |
Forfeited |  |  | (225,413 | ) |  | $ | 2.37 |  |  |  |  |  |  |  |  |
Balance – December 31, 2012 |  |  | 4,453,746 |  |  | $ | 1.78 |  |  |  | 6.43 years |  |  | $ | 1,308,000 |
Granted |  |  | 222,500 |  |  | $ | 1.69 |  |  |  |  |  |  |  |  |
Exercised |  |  | (291,666 | ) |  | $ | 0.79 |  |  |  |  |  |  | $ | 71,000 |
Forfeited |  |  | (475,000 | ) |  | $ | 2.30 |  |  |  |  |  |  |  |  |
Balance – December 31, 2013 |  |  | 3,909,580 |  |  | $ | 1.78 |  |  |  | 5.59 years |  |  | $ | 785,000 |
Granted |  |  | 2,382,500 |  |  | $ | 2.36 |  |  |  |  |  |  |  |  |
Exercised |  |  | (6,583 | ) |  | $ | 0.58 |  |  |  |  |  |  | $ | 8,000 |
Forfeited |  |  | (304,391 | ) |  | $ | 1.93 |  |  |  |  |  |  |  |  |
Balance – December 31, 2014 – outstanding |  |  | 5,981,106 |  |  | $ | 2.01 |  |  |  | 5.80 years |  |  | $ | 685,000 |
Balance – December 31, 2014 – exercisable |  |  | 3,893,196 |  |  | $ | 1.85 |  |  |  | 5.12 years |  |  | $ | 685,000 |
Grant date fair value of options granted – 2014 |  |  |  |  |  | $ | 4,974,000 |  |  |  |  |  |  |  |  |
Weighted average grant date fair value – 2014 |  |  |  |  |  | $ | 2.09 |  |  |  |  |  |  |  |  |
Grant date fair value of options granted – 2013 |  |  |  |  |  | $ | 350,000 |  |  |  |  |  |  |  |  |
Weighted average grant date fair value – 2013 |  |  |  |  |  | $ | 1.57 |  |  |  |  |  |  |  |  |
Grant date fair value of options granted – 2012 |  |  |  |  |  | $ | 4,468,000 |  |  |  |  |  |  |  |  |
Weighted average grant date fair value – 2012 |  |  |  |  |  | $ | 2.15 |  |  |  |  |  |  |  |  |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] | The options outstanding and exercisable at December 31, 2014 are as follows:
|  | Options Outstanding |  | Options Exercisable
|  | Range of Exercise Price |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life
|  | $ | 0.09 – $2.00 |  |  |  | 2,703,280 |  |  | $ | 1.37 |  |  |  | 4.33 years |  |  |  | 2,018,074 |  |  | $ | 1.28 |  |  |  | 3.73 years |
|  | $ | 2.01 – $3.00 |  |  |  | 3,232,002 |  |  |  | 2.49 |  |  |  | 7.08 years |  |  |  | 1,829,298 |  |  |  | 2.40 |  |  |  | 6.73 years |
|  | $ | 3.01 – $6.00 |  |  |  | 45,824 |  |  |  | 5.24 |  |  |  | 2.62 years |  |  |  | 45,824 |  |  |  | 5.24 |  |  |  | 2.62 years |
|  | $ | 0.09 – $6.00 |  |  |  | 5,981,106 |  |  | $ | 2.01 |  |  |  | 5.80 years |  |  |  | 3,893,196 |  |  | $ | 1.85 |  |  |  | 5.12 years |
The options outstanding and exercisable at December 31, 2013 are as follows:
|  | Options Outstanding |  | Options Exercisable
|  | Range of Exercise Price |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life
|  | $ | 0.09 – $2.00 |  |  |  | 2,093,196 |  |  | $ | 1.29 |  |  |  | 4.73 years |  |  |  | 1,901,737 |  |  | $ | 1.25 |  |  |  | 4.64 years |
|  | $ | 2.01 – $3.00 |  |  |  | 1,770,560 |  |  |  | 2.28 |  |  |  | 6.65 years |  |  |  | 1,205,976 |  |  |  | 2.26 |  |  |  | 6.25 years |
|  | $ | 3.01 – $6.00 |  |  |  | 45,824 |  |  |  | 5.24 |  |  |  | 3.62 years |  |  |  | 45,824 |  |  |  | 5.24 |  |  |  | 3.62 years |
|  | $ | 0.09 – $6.00 |  |  |  | 3,909,580 |  |  | $ | 1.78 |  |  |  | 5.59 years |  |  |  | 3,153,537 |  |  | $ | 1.69 |  |  |  | 5.24 years |
The options outstanding and exercisable at December 31, 2012 are as follows:
|  | Options Outstanding |  | Options Exercisable
|  | Range of Exercise Price |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life
|  | $ | 0.09 – $2.00 |  |  |  | 2,162,362 |  |  | $ | 1.78 |  |  |  | 5.76 years |  |  |  | 1,801,187 |  |  | $ | 1.14 |  |  |  | 5.52 years |
|  | $ | 2.01 – $3.00 |  |  |  | 2,212,227 |  |  |  | 2.26 |  |  |  | 7.15 years |  |  |  | 1,011,533 |  |  |  | 2.17 |  |  |  | 6.14 years |
|  | $ | 3.01 – $6.00 |  |  |  | 79,157 |  |  |  | 4.87 |  |  |  | 4.49 years |  |  |  | 79,157 |  |  |  | 4.87 |  |  |  | 4.49 years |
|  | $ | 0.09 – $6.00 |  |  |  | 4,453,746 |  |  | $ | 1.78 |  |  |  | 6.43 years |  |  |  | 2,891,877 |  |  | $ | 1.60 |  |  |  | 5.71 years |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Non Vested and Expected to Vest Exercisable [Table Text Block] | The following is a summary of the Company’s non-vested stock options at December 31, 2014:
|  | Unvested Stock Options |  | Weighted Average Grant Date Fair Value
Non-vested – December 31, 2011 |  |  | 524,403 |  |  | $ | 0.82 |
Granted |  |  | 2,075,000 |  |  |  | 2.21 |
Vested/Exercised |  |  | (891,332 | ) |  |  | 0.81 |
Forfeited/Cancelled |  |  | (146,202 | ) |  |  | 1.79 |
Non-vested – December 31, 2012 |  |  | 1,561,869 |  |  | $ | 2.11 |
Granted |  |  | 222,500 |  |  |  | 1.69 |
Vested/Exercised |  |  | (883,882 | ) |  |  | 1.93 |
Forfeited/Cancelled |  |  | (144,444 | ) |  |  | 2.27 |
Non-vested – December 31, 2013 |  |  | 756,043 |  |  |  | 2.17 |
Granted |  |  | 2,382,500 |  |  |  | 2.36 |
Vested/Exercised |  |  | (1,050,633 | ) |  |  | 2.35 |
Non-vested – December 31, 2014 |  |  | 2,087,910 |  |  | $ | 2.30 |
Weighted average remaining period for vesting |  |  | 2.15 years |  |  |  |  |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] | The assumptions used by the Company are summarized in the following table:
|  | Issuance Date |  | December 31, 2014
Closing stock price |  |  | $1.75 |  |  |  | $1.46 |
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 95 | % |  |  | 90 | %
Risk free interest rate |  |  | 1.39 | % |  |  | 1.59 | %
Expected life of warrant |  |  | 5 years |  |  |  | 4.79 years |
Schedule Of Estimated Fair Value Of The Warrant Liability [Table Text Block] | The following table summarizes the estimated fair value of the warrant liability (in thousands):
Balance at December 31, 2013 |  | $ | — |
Warrants liability |  |  | 7,376 |
Change in fair value of warrant liability |  |  | (620 | )
Balance at December 31, 2014 |  | $ | 6,756 |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | The assumptions used by the Company are summarized in the following table:
Exercise price |  |  | $2.20 |
Expected dividends |  |  | 0 | %
Expected volatility |  |  | 110 | %
Risk free interest rate |  |  | 0.26 | %
Expected life of warrant |  |  | 2 years |
The assumptions used by the Company are summarized in the following table:
Exercise price |  |  | $1.14 |
Expected dividends |  |  | 0 | %
Expected volatility |  |  | 174 | %
Risk free interest rate |  |  | 0.71 | %
Expected life of warrant |  |  | 5 years |
Schedule of Warrant Activity [Table Text Block] | A summary of warrant activity for the Company for the years ended December 31, 2014, 2013 and 2012 is as follows:
|  | Number of Warrants |  | Weighted Average Exercise Price
Balance at December 31, 2011 |  |  | 3,259,186 |  |  | $ | 1.95 |
Granted |  |  | 985,855 |  |  | $ | 1.71 |
Exercised |  |  | (1,768,167 | ) |  | $ | 1.11 |
Forfeited |  |  | (844,373 | ) |  | $ | 3.32 |
Balance at December 31, 2012 |  |  | 1,632,501 |  |  | $ | 1.99 |
Granted |  |  | — |  |  | $ | — |
Exercised |  |  | — |  |  | $ | — |
Forfeited |  |  | — |  |  | $ | — |
Balance at December 31, 2013 |  |  | 1,632,501 |  |  | $ | 1.99 |
Granted |  |  | 7,029,808 |  |  | $ | 1.75 |
Exercised |  |  | (232,619 | ) |  | $ | 1.47 |
Forfeited |  |  | (454,896 | ) |  | $ | 1.88 |
Balance at December 31, 2014 |  |  | 7,974,794 |  |  | $ | 1.80 |
Schedule of Warrant Outstanding and Exercisable [Table Text Block] | A summary of all outstanding and exercisable warrants as of December 31, 2014 is as follows:
|  | Exercise Price |  | Warrants Outstanding |  | Warrants Exercisable |  | Weighted Average Remaining Contractual Life
|  |  | $1.60 |  |  |  | 316,522 |  |  |  | 316,522 |  |  |  | 2.82 years |
|  |  | $1.75 |  |  |  | 7,029,808 |  |  |  | 7,029,808 |  |  |  | 4.78 years |
|  |  | $2.22 |  |  |  | 517,257 |  |  |  | 517,257 |  |  |  | 1.91 years |
|  |  | $3.30 |  |  |  | 61,207 |  |  |  | 61,207 |  |  |  | 0.41 years |
|  |  | $3.75 |  |  |  | 50,000 |  |  |  | 50,000 |  |  |  | 1.13 years |
|  |  | $1.99 |  |  |  | 7,974,794 |  |  |  | 7,974,794 |  |  |  | 4.46 years |

X
- Definition Tabular disclosure of estimated fair value of the warrant liability. + References No definition available. + Details
Name: | syn_ScheduleOfEstimatedFairValueOfWarrantLiabilityTableTextBlock
Namespace Prefix: | syn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrant activity. + References No definition available. + Details
Name: | syn_ScheduleOfWarrantActivityTableTextBlock
Namespace Prefix: | syn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure relates to warrant outstanding and exercisable. + References No definition available. + Details
Name: | syn_ScheduleOfWarrantOutstandingAndExercisableTableTextBlock
Namespace Prefix: | syn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure relates to share based compensation arrangement by share based payment award options and warrants vested and expected to vest outstanding and exercisable. + References No definition available. + Details
Name: | syn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | syn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure relates to share based compensation arrangement by share based payment award non vested stock options and expected to vest outstanding and exercisable. + References No definition available. + Details
Name: | syn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix: | syn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the inputs and valuation techniques used to measure fair value, and a discussion of changes in valuation techniques and related inputs, if any, applied during the period to each separate class of assets, liabilities, and financial instruments classified in shareholders' equity that are measured on a recurring and/or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term for both options (or share units) currently outstanding and options (or share units) exercisable (or convertible). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration